Literature DB >> 11340524

Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases.

K C Reid1, F R Cockerill III, R Patel.   

Abstract

The clinical significance of intrinsically vancomycin-resistant enterococci is not yet fully established, as these organisms are infrequently recovered from clinical specimens. We report our experience with 20 cases of Enterococcus gallinarum and Enterococcus casseliflavus/flavescens bacteremia in humans from 1992 through 1998. Sixteen cases of bacteremia were caused by E. gallinarum. Underlying conditions were present in 19 (95%) of the patients and included malignancy, receipt of transplant, and Caroli's disease. Polymicrobial bacteremia was present in 9 patients (45%). E. gallinarum and E. casseliflavus/flavescens, although they are infrequently isolated from clinical specimens, may cause serious invasive infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340524     DOI: 10.1086/320542

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Enterococcus gallinarum endocarditis occurring on native heart valves.

Authors:  Sylvie Dargere; Michel Vergnaud; Renaud Verdon; Eric Saloux; Olivier Le Page; Roland Leclercq; Claude Bazin
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Isolation and identification of ATP-secreting bacteria from mice and humans.

Authors:  Tadayuki Iwase; Hitomi Shinji; Akiko Tajima; Fumiya Sato; Taku Tamura; Takeo Iwamoto; Minoru Yoneda; Yoshimitsu Mizunoe
Journal:  J Clin Microbiol       Date:  2010-03-19       Impact factor: 5.948

3.  Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Armin Rashidi; Maryam Ebadi; Robin R Shields-Cutler; Todd E DeFor; Gabriel A Al-Ghalith; Patricia Ferrieri; Jo-Anne H Young; Gary M Dunny; Dan Knights; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-31       Impact factor: 5.742

4.  Origin and diversity of metabolically active gut bacteria from laboratory-bred larvae of Manduca sexta (Sphingidae, Lepidoptera, Insecta).

Authors:  Nicole Brinkmann; Rainer Martens; Christoph C Tebbe
Journal:  Appl Environ Microbiol       Date:  2008-10-10       Impact factor: 4.792

5.  Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections.

Authors:  Nicholas S Britt; Emily M Potter
Journal:  J Glob Antimicrob Resist       Date:  2015-12-21       Impact factor: 4.035

6.  Characterization of an Enterococcus gallinarum Isolate Carrying a Dual vanA and vanB Cassette.

Authors:  Alireza Eshaghi; Dea Shahinas; Aimin Li; Ruwandi Kariyawasam; Philip Banh; Marc Desjardins; Roberto G Melano; Samir N Patel
Journal:  J Clin Microbiol       Date:  2015-05-06       Impact factor: 5.948

7.  Vancomycin-resistant Enterococcus spp. isolated from wastewater and chicken feces in the United States.

Authors:  V J Harwood; M Brownell; W Perusek; J E Whitlock
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

Review 8.  Management of multidrug-resistant enterococcal infections.

Authors:  C A Arias; G A Contreras; B E Murray
Journal:  Clin Microbiol Infect       Date:  2010-06       Impact factor: 8.067

9.  Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation.

Authors:  Armin Rashidi; Maryam Ebadi; Robin R Shields-Cutler; Kathryn Kruziki; Dawn A Manias; Aaron M T Barnes; Todd E DeFor; Patricia Ferrieri; Jo-Anne H Young; Dan Knights; Bruce R Blazar; Daniel J Weisdorf; Gary M Dunny
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

Review 10.  The Enterococcus: a Model of Adaptability to Its Environment.

Authors:  Mónica García-Solache; Louis B Rice
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.